Automated SMS-Based Appointment Validation Tool
This study is not yet open for participant recruitment.
Verified August 2012 by Medic Mobile
Sponsor:
Medic Mobile
Collaborator:
San Mateo Medical Center
Information provided by (Responsible Party):
Medic Mobile
ClinicalTrials.gov Identifier:
NCT01671189
First received: August 20, 2012
Last updated: August 22, 2012
Last verified: August 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Medic Mobile conceptualized and proposed the creation of an SMS-based appointment validation tool to automate appointment confirmation and rescheduling. Working in parallel with the San Mateo Medical Center (SMMC) electronic medical records (EMR) system, the software tool will automate reminders that request text responses from patients to either confirm or request to reschedule their upcoming appointments. While simple in concept, this tool aims to free up scarce clinical resources which are currently allocated to daily patient phone call reminders. With funding from a Bay Area foundation, the investigators will develop and pilot this open-source software tool in a 12-month randomized-controlled trial, slated to begin in October 2012. The endpoints of the study will aim to demonstrate improvements in both appointment adherence and glycemic control.
| Condition | Intervention | Phase |
|---|---|---|
|
Diabetes Mellitus Type 2 Adult-onset Diabetes |
Other: SMS Reminder Software Tool |
Phase 0 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Prevention |
| Official Title: | An Automated SMS-Based Reminder and Rescheduling Tool to Improve Appointment Adherence Rates and Glycemic Control Among Diabetes Patients in San Mateo County |
Resource links provided by NLM:
Further study details as provided by Medic Mobile:
Primary Outcome Measures:
- Glycemic Control (hemoglobin A1c) [ Time Frame: 6-9 months post-enrollment ] [ Designated as safety issue: No ]The hemoglobin A1c (HbA1c) levels of study participants will be measured at the time of enrollment and at the end of the 6-9 month follow-up period.
Secondary Outcome Measures:
- Appointment Adherence Rate [ Time Frame: 6-9 month post-enrollment ] [ Designated as safety issue: No ]Appointments scheduled during the 6-9 month follow-up period will be systematically tracked and monitored. The proportion of fulfilled appointments will be compared between the intervention and control arms.
| Estimated Enrollment: | 300 |
| Study Start Date: | October 2012 |
| Estimated Study Completion Date: | December 2013 |
| Estimated Primary Completion Date: | October 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: SMS Appointment Reminders
150 patients will be randomly assigned to the intervention arm of the study and receive text reminders about their upcoming appointments.
|
Other: SMS Reminder Software Tool
The 150 patients in the intervention arm of the study will receive SMS reminders regarding their upcoming appointments. Working in parallel with the SMMC electronic medical records system, the software tool will automate reminders that request text responses from patients to either confirm or request to reschedule their upcoming appointments. This bidirectional text messaging system would not interfere with the clinics' existing reminder protocol.
|
|
No Intervention: Existing Reminder Protocol
150 patients will be randomly assigned to the control arm of the study and will not receive SMS reminders about their upcoming appointments. They will, however, be subject to the clinics' existing reminder protocol (phone call reminders by either clinic personnel or computer machine).
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Belong to Willow Clinic or Fair Oaks Clinic under the San Mateo Medical Center
- Have a diagnosis of type 2 diabetes as indicated by ICD-9 code of 249.xx or 250.xx
- Have a most recent hemoglobin A1c (HbA1c) level greater than 7%
- Are at least 18 years of age
- Have access to cell phone
- Are literate or live with a friend/family member who is literate and willing to handle associated text messages
Exclusion Criteria:
- Have a terminal illness and prognosis of less than one year
- Are unable to demonstrate the ability to reply to an SMS and lack an appropriate proxy
- Are pregnant or expect to be pregnant in the next 6-9 months
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01671189
Contacts
| Contact: Jessica Qu | 415-728-2208 | jessica@medicmobile.org |
| Contact: Mainul Islam | 415-328-7657 | mainul@medicmobile.org |
Locations
| United States, California | |
| San Mateo Medical Center | Not yet recruiting |
| San Mateo, California, United States, 94403 | |
| Contact: Mike Aratow, Dr. MAratow@smcgov.org | |
| Contact: Jeanette Aviles, Dr. javiles@smcgov.org | |
Sponsors and Collaborators
Medic Mobile
San Mateo Medical Center
Investigators
| Principal Investigator: | Nadim Mahmud | Medic Mobile |
More Information
Additional Information:
No publications provided
| Responsible Party: | Medic Mobile |
| ClinicalTrials.gov Identifier: | NCT01671189 History of Changes |
| Other Study ID Numbers: | SMMC-MCK-2012 |
| Study First Received: | August 20, 2012 |
| Last Updated: | August 22, 2012 |
| Health Authority: | United States: Institutional Review Board |
Additional relevant MeSH terms:
|
Diabetes Mellitus Diabetes Mellitus, Type 2 Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases |
ClinicalTrials.gov processed this record on May 21, 2013